Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Hereditary leiomyomatosis and renal cell cancer × Temozolomide × 1 year × Clear all

Sponsor

Conditions

Glioblastoma 93 Glioma 36 Brain Neoplasms 21 Neuroblastoma 20 Gliosarcoma 15 Astrocytoma 15 Sarcoma, Ewing 12 Rhabdomyosarcoma 11 Recurrence 10 Medulloblastoma 10 Small Cell Lung Carcinoma 7 Sarcoma 7 Neoplasms 7 Oligodendroglioma 6 Melanoma 6 Ependymoma 6 Diffuse Intrinsic Pontine Glioma 6 Osteosarcoma 5 Prostatic Neoplasms 4 Ovarian Neoplasms 3 Neuroendocrine Tumors 3 Neoplasm Metastasis 3 Lymphoma, Follicular 3 Lymphoma 3 Lung Neoplasms 3 Colorectal Neoplasms 3 Adenoma, Islet Cell 3 Wilms Tumor 2 Somatostatinoma 2 Rhabdoid Tumor 2

Interventions

spartalizumab 1 atezolizumab 1 Specimen Handling 1 Magnetic Resonance Spectroscopy 1 Immunoglobulin G 1 Everolimus 1 Erlotinib Hydrochloride 1 Disulfides 1 Contrast Media 1 Biopsy 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡